Human Placental Tissue Contains A Placental Lactogen-Derived Vasoinhibin

J Endocr Soc. 2022 Feb 20;6(4):bvac029. doi: 10.1210/jendso/bvac029. eCollection 2022 Apr 1.

Abstract

Hormonal factors affecting the vascular adaptions of the uteroplacental unit in noncomplicated and complicated pregnancies are of interest. Here, 4 human placentas from women with and without preeclampsia (PE) were investigated for the presence of placental lactogen (PL)-derived, antiangiogenic vasoinhibin. Western blotting and mass spectrometry of placental tissue revealed the presence of a 9-kDa PL-derived vasoinhibin, the normal 22-kDa full-length PL, and a 28-kDa immunoreactive protein of undetermined nature. The sequence of the 9-kDa vasoinhibin includes the antiangiogenic determinant of vasoinhibin and could constitute a relevant factor in normal pregnancy and PE.

Keywords: placenta; placental lactogen; preeclampsia; vasoinhibin.